InvestorsHub Logo
Followers 3
Posts 60
Boards Moderated 0
Alias Born 02/20/2019

Re: johnnyblades2001 post# 21

Wednesday, 01/22/2020 3:56:55 PM

Wednesday, January 22, 2020 3:56:55 PM

Post# of 26
I may be wrong but I thought the company's focus is developing products for out licensing opportunities. In other words VT develops a product and allows pharma A to licenses it at it's current stage of development or pay VT a fee to continue developing it and pay milestone payments as VT meets predetermined goals---and if launched, Pharma A pays VT royalties. There are many different scenarios for VT to get paid and paid well without having to commercialize the developed products. All good stuff. I provided a link to another company that uses that same business model and they are are doing very well.

Here it is: https://www.ligand.com/about/overview

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.